Liebert, Ann
Bicknell, Brian
Laakso, E-Liisa
Tilley, Sharon
Heller, Gillian
Kiat, Hosen
Herkes, Geoffrey
Article History
Received: 31 May 2024
Accepted: 9 September 2024
First Online: 9 October 2024
Declarations
:
: The study received human research ethics approval by the Griffith University Human Research Ethics Committee (2018/16), with an extension to 24th April 2024. All participants gave written informed consent prior to taking part in the study. All protocols were approved by the Griffith University Human Research Ethics Committee and were conducted in accordance with their regulations and guidelines.
: Not applicable.
: AL and BB are co-founders, and shareholders in SYMBYX Pty Ltd, a med-tech company developing photobiomodulation treatments for neurological disorders. HK and ELL are shareholders in SYMBYX Pty Ltd.